Tessari Eben bought KNSA
September 5, 2025 · Form 4 insider transaction
Tessari Eben bought 13,389 shares of Kiniksa Pharmaceuticals International, plc at $15.52 per share, a transaction worth $207.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,389
Price
$15.52
Total value
$207.8K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 5, 2025
Filing dateSeptember 8, 2025
Shares owned after57,841
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.